Boni Maciej F, Gog Julia R, Andreasen Viggo, Christiansen Freddy B
Department of Zoology, University of Cambridge, Downing Street, Cambridge CB2 3EJ, UK.
Theor Popul Biol. 2004 Mar;65(2):179-91. doi: 10.1016/j.tpb.2003.10.002.
Influenza in humans is characterised by strongly annual dynamics and antigenic evolution leading to partial escape from prior host immunity. The variability of new epidemic strains depends on the amount of virus currently circulating. In this paper, the amount of antigenic variation produced each year is dependent on the epidemic size. Our model reduces to a one-dimensional map and a full mathematical analysis is presented. This simple system suggests some basic principles which may be more generally applicable. In particular, for diseases with antigenic drift, vaccination may be doubly beneficial. Not only does it protect the population through classical herd immunity, but the overall case reduction reduces the chance of new variants being produced; hence, subsequent epidemics may be milder as a result of this positive feedback. Also, a disease with a high innate rate of antigenic variation will always be able to invade a susceptible population, whereas a disease with less potential for variation may require several introduction events to become endemic.
人类流感的特点是具有强烈的年度动态变化以及抗原进化,从而导致部分逃脱先前宿主的免疫力。新流行毒株的变异性取决于当前正在传播的病毒量。在本文中,每年产生的抗原变异量取决于流行规模。我们的模型简化为一个一维映射,并给出了完整的数学分析。这个简单的系统提出了一些可能更具普遍适用性的基本原理。特别是,对于具有抗原漂移的疾病,疫苗接种可能具有双重益处。它不仅通过经典的群体免疫保护人群,而且总体病例数的减少降低了产生新变种的机会;因此,由于这种正反馈,随后的疫情可能会更温和。此外,具有高固有抗原变异率的疾病总能侵入易感人群,而变异潜力较小的疾病可能需要多次引入事件才能成为地方病。